Shinobi co-founder publishes preclinical data validating its Katana platform
The study shows IL-15 and IL-21 co-expression in iPSC-derived CAR-T cells improves tumor homing, persistence and anti-tumor activity in solid tumor models, cytokines also used in its NJA-001 candidate.